Evidence map›Paper›PMID 18836035›Full record

ArticleGenome research2008

Active Alu retrotransposons in the human genome.

E Andrew Bennett, Heiko Keller, Ryan E Mills, Steffen Schmidt, John V Moran, Oliver Weichenrieder, Scott E Devine

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 179 papers.

0numbers the graph read from it
0cells of the map it votes in
179citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

179 citing papers in PubMed, 280 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Direct identification ofbioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. A multi-omics analysis of human fibroblasts overexpressing anbioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The topography of nullomer-emerging mutations and their relevance to human disease.Computational and structural biotechnology journal · 2025
    Article
  19. Article
  20. Article

119 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

E Andrew BennettGenetics and Molecular Biology Graduate Program, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Heiko Keller
Ryan E Mills
Steffen Schmidt
John V Moran
Oliver Weichenrieder
Scott E Devine
Emory University · USMax Planck Institute for Developmental Biology · DEHoward Hughes Medical Institute · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008490 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2022
$8.0M
Gen. &Mol. Analysis of Human LINE-1 RetrotranspositionR01GM060518 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORAN, JOHN V. · 1999 to 2024
$4.8M
Natural Genetic Variation in the Human GenomeR01HG002898 · NHGRI · UNIVERSITY OF MARYLAND BALTIMORE · PI DEVINE, SCOTT E · 2004 to 2019
$3.7M
Improving INDEL Identification in Genomic SequencesF32HG004207 · NHGRI · EMORY UNIVERSITY · PI MILLS, RYAN E · 2006 to 2008
$99k
NHGRI NIH HHS F32 HG004207NHGRI NIH HHS F32HG004207NHGRI NIH HHS R01 HG002898NHGRI NIH HHS R01HG002898NIGMS NIH HHS R01 GM060518NIGMS NIH HHS R01GM060518NIGMS NIH HHS T32 GM008490
6 · The paper itself

Abstract

Alu retrotransposons evolved from 7SL RNA approximately 65 million years ago and underwent several rounds of massive expansion in primate genomes. Consequently, the human genome currently harbors 1.1 million Alu copies. Some of these copies remain actively mobile and continue to produce both genetic variation and diseases by "jumping" to new genomic locations. However, it is unclear how many active Alu copies exist in the human genome and which Alu subfamilies harbor such copies. Here, we present a comprehensive functional analysis of Alu copies across the human genome. We cloned Alu copies from a variety of genomic locations and tested these copies in a plasmid-based mobilization assay. We show that functionally intact core Alu elements are highly abundant and far outnumber all other active transposons in humans. A range of Alu lineages were found to harbor such copies, including all modern AluY subfamilies and most AluS subfamilies. We also identified two major determinants of Alu activity: (1) The primary sequence of a given Alu copy, and (2) the ability of the encoded RNA to interact with SRP9/14 to form RNA/protein (RNP) complexes. We conclude that Alu elements pose the largest transposon-based mutagenic threat to the human genome. On the basis of our data, we have begun to identify Alu copies that are likely to produce genetic variation and diseases in humans.

Indexed as

Alu ElementsGenome, HumanRetroelementsEvolution, MolecularGenetic VariationHeLa CellsHumansModels, GeneticModels, MolecularRetroelements

Identifiers

PMID18836035
PMCPMC2593586
OpenAlexW2054890113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.